US Stock MarketDetailed Quotes

CMMB Chemomab Therapeutics

Watchlist
  • 1.820
  • +0.040+2.25%
Close Nov 29 13:00 ET
  • 1.800
  • -0.020-1.10%
Post 17:01 ET
34.32MMarket Cap-1936P/E (TTM)

About Chemomab Therapeutics Company

Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.

Company Profile

SymbolCMMB
Company NameChemomab Therapeutics
Listing DateFeb 12, 2019
Issue Price11.50
Founded2011
CEODr. Adi Mor, PhD
MarketNASDAQ
Employees20
Securities TypeDR
ADS Ratio1.0 : 20.0
Fiscal Year Ends12-31
AddressKiryat Atidim,Building 7
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6158002
Phone972-77-331-0156
Websitehttp://www.chemomab.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Adi Mor, PhD
  • Chief Executive Officer, Chief Scientific Officer and Director
  • 435.40K
  • Sigal Fattal
  • Chief Financial Officer
  • --
  • Dr. Matthew B. Frankel
  • Chief Medical Officer
  • --
  • Dr. Nissim Darvish, M.D.,PhD
  • Chairman of the Board
  • 123.00K
  • Jill M. Quigley, Esq.
  • Independent Director
  • 38.00K
  • Neil Cohen
  • Independent Director
  • 123.00K
  • Dr. Alan C. Moses, F.A.C.P.,M.D.
  • Independent Director
  • 119.00K
  • Dr. Claude Nicaise,M.D.
  • Independent Director
  • 123.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data